Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Pacific Valley Bank (PVBK) Tops Q3 EPS by 24c
- Christopher & Banks (CBK) Tops Q3 EPS by 79c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
